DBVT

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

DBV Technologies

NASDAQ | DBVT

13.00

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 3, 2025)

$520.71M

Market Cap

-

P/E Ratio

-5.2

EPS

$18.00

52 Week High

$2.74

52 Week Low

HEALTHCARE

Sector

DBVT Chart

Recent Chart
Price Action

DBVT Technicals

Tags:

DBVT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$6.8M
Total Revenue $2.6M
Cost Of Revenue $6.8M
Costof Goods And Services Sold $6.8M
Operating Income -$121M
Selling General And Administrative $29M
Research And Development $90M
Operating Expenses $114M
Investment Income Net -
Net Interest Income $2.7M
Interest Income -
Interest Expense $740K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.8M
Income Before Tax -$118M
Income Tax Expense -$4.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$114M
Comprehensive Income Net Of Tax -
Ebit -$118M
Ebitda -$111M
Net Income -$114M

Revenue & Profitability

Earnings Performance

DBVT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $66M
Total Current Assets $44M
Cash And Cash Equivalents At Carrying Value $32M
Cash And Short Term Investments $32M
Inventory -
Current Net Receivables $10M
Total Non Current Assets $21M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $40K
Intangible Assets Excluding Goodwill $40K
Goodwill -
Investments -
Long Term Investments $4.3M
Short Term Investments -
Other Current Assets $1.5M
Other Non Current Assets -
Total Liabilities $38M
Total Current Liabilities $31M
Current Accounts Payable $22M
Deferred Revenue -
Current Debt -
Short Term Debt $1.5M
Total Non Current Liabilities $7.1M
Capital Lease Obligations $7M
Long Term Debt -
Current Long Term Debt $846K
Long Term Debt Noncurrent -
Short Long Term Debt Total $7.8M
Other Current Liabilities $7.4M
Other Non Current Liabilities $838K
Total Shareholder Equity $27M
Treasury Stock -
Retained Earnings -$286M
Common Stock $12M
Common Stock Shares Outstanding $19M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$104M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -$925K
Capital Expenditures $2.3M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$757K
Cashflow From Financing $587K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$47K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$114M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$6.8M
Total Revenue $2.6M
Cost Of Revenue $6.8M
Costof Goods And Services Sold $6.8M
Operating Income -$121M
Selling General And Administrative $29M
Research And Development $90M
Operating Expenses $114M
Investment Income Net -
Net Interest Income $2.7M
Interest Income -
Interest Expense $740K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.8M
Income Before Tax -$118M
Income Tax Expense -$4.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$114M
Comprehensive Income Net Of Tax -
Ebit -$118M
Ebitda -$111M
Net Income -$114M

DBVT News

DBVT Profile

DBV Technologies Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

DBV Technologies SA (DBVT) is a pioneering biopharmaceutical company headquartered in Montrouge, France, focused on revolutionizing food allergy treatment through its proprietary Viaskinâ„¢ technology platform. As a clinical-stage organization, DBV is dedicated to developing non-invasive epicutaneous immunotherapies aimed at promoting allergen desensitization, with a primary focus on peanut allergies. The company is currently advancing a robust pipeline through a series of clinical trials, positioning itself as a leader in addressing significant unmet medical needs in allergy management while striving to improve patient quality of life.

LPTX
+368.57%
$2.05
PAVS
-40.10%
$0.03
VRAX
+58.18%
$0.62
IXHL
+15.22%
$0.45
IRBT
+59.74%
$3.11
VHAI
0.00%
$0.00
CMND
-9.93%
$0.12
NVDA
-0.72%
$180.14
ONDS
+5.27%
$8.49
TWOH
0.00%
$0.00
PLUG
+3.31%
$2.18
IPG
-1.95%
$24.57
TSLA
+4.04%
$446.61
NIO
-5.56%
$4.75
ASST
-1.44%
$1.02
RR
+16.15%
$4.13
AXDX
-61.36%
$0.03
BYND
-6.20%
$1.21
BITF
-0.01%
$3.09
INTC
-0.01%
$43.46
QCLS
+36.68%
$4.62
IREN
+6.23%
$43.68
CAPR
+341.43%
$28.07
ADAP
-15.14%
$0.05
VALE
+3.45%
$13.33
AAL
+2.03%
$14.53
BBD
-2.31%
$3.58
SOND
-23.45%
$0.12
NFLX
-4.89%
$103.99
MRVL
+7.24%
$99.61
CAN
+2.04%
$0.96
INHD
-8.15%
$0.13
RMBL
+60.50%
$3.21
SOFI
-0.24%
$29.43
DNN
+4.05%
$2.69
LNW
-3.71%
$86.22
BMNR
+3.68%
$33.08
ADD
-25.47%
$0.05
BMNU
+10.90%
$8.14
PFE
+2.24%
$25.71
SRM
+53.27%
$10.30
MARA
+4.19%
$12.41
F
+0.84%
$13.07
SGMO
+3.47%
$0.44
ACHR
+5.62%
$8.08
BTBT
+3.34%
$2.31
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
AEO
+14.50%
$23.85
AAPL
-0.61%
$284.42
PLTD
-2.72%
$6.77
CLSK
+4.99%
$14.39
CIFR
+3.59%
$18.27
QBTS
+6.57%
$23.97
WULF
+0.59%
$14.30
PLTR
+2.56%
$175.07
RIG
+3.48%
$4.46
KVUE
-0.54%
$16.76
AFMD
-34.94%
$0.18
GOOGL
+1.65%
$321.02
AMZN
-0.95%
$232.17
IMRN
-9.19%
$1.58
CHR
-5.80%
$0.04
AVGO
-1.16%
$381.57
ASBP
-8.00%
$0.09
AMD
+0.75%
$216.87
MSFT
-1.69%
$481.70
PCG
-0.78%
$15.20
PMAX
+27.97%
$2.90
DRCT
-15.28%
$0.10
RIVN
+2.25%
$17.61
HTOO
+15.71%
$4.05
HOOD
+6.29%
$133.88
PYPL
-2.55%
$61.29
CGC
+4.95%
$1.16
GRYP
-10.38%
$1.38
BTG
+0.56%
$4.45
BMY
+5.64%
$50.97
MODV
-25.22%
$0.43
BAC
+1.67%
$54.08
HBAN
+2.62%
$16.99
GRAB
-0.85%
$5.21
MSTR
+2.50%
$185.87
RGTI
+4.06%
$24.85
GTLB
-13.46%
$37.53
M
+0.61%
$22.85
VIVK
-15.17%
$0.09
PSTG
-26.92%
$69.21
NOK
+1.20%
$6.26
DVLT
-3.19%
$1.82
YGMZ
-13.57%
$0.07
ITUB
+0.19%
$7.90
CRDO
+10.11%
$188.44
ALIT
-2.47%
$2.17
SNAP
+0.13%
$7.63
FCX
+4.22%
$44.78
CRCL
+8.61%
$84.11
ABEV
+1.34%
$2.61
BE
+6.13%
$105.00
GPUS
-2.71%
$0.27
LPTX
+368.57%
$2.05
PAVS
-40.10%
$0.03
VRAX
+58.18%
$0.62
IXHL
+15.22%
$0.45
IRBT
+59.74%
$3.11
VHAI
0.00%
$0.00
CMND
-9.93%
$0.12
NVDA
-0.72%
$180.14
ONDS
+5.27%
$8.49
TWOH
0.00%
$0.00
PLUG
+3.31%
$2.18
IPG
-1.95%
$24.57
TSLA
+4.04%
$446.61
NIO
-5.56%
$4.75
ASST
-1.44%
$1.02
RR
+16.15%
$4.13
AXDX
-61.36%
$0.03
BYND
-6.20%
$1.21
BITF
-0.01%
$3.09
INTC
-0.01%
$43.46
QCLS
+36.68%
$4.62
IREN
+6.23%
$43.68
CAPR
+341.43%
$28.07
ADAP
-15.14%
$0.05
VALE
+3.45%
$13.33
AAL
+2.03%
$14.53
BBD
-2.31%
$3.58
SOND
-23.45%
$0.12
NFLX
-4.89%
$103.99
MRVL
+7.24%
$99.61
CAN
+2.04%
$0.96
INHD
-8.15%
$0.13
RMBL
+60.50%
$3.21
SOFI
-0.24%
$29.43
DNN
+4.05%
$2.69
LNW
-3.71%
$86.22
BMNR
+3.68%
$33.08
ADD
-25.47%
$0.05
BMNU
+10.90%
$8.14
PFE
+2.24%
$25.71
SRM
+53.27%
$10.30
MARA
+4.19%
$12.41
F
+0.84%
$13.07
SGMO
+3.47%
$0.44
ACHR
+5.62%
$8.08
BTBT
+3.34%
$2.31
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
AEO
+14.50%
$23.85
AAPL
-0.61%
$284.42
PLTD
-2.72%
$6.77
CLSK
+4.99%
$14.39
CIFR
+3.59%
$18.27
QBTS
+6.57%
$23.97
WULF
+0.59%
$14.30
PLTR
+2.56%
$175.07
RIG
+3.48%
$4.46
KVUE
-0.54%
$16.76
AFMD
-34.94%
$0.18
GOOGL
+1.65%
$321.02
AMZN
-0.95%
$232.17
IMRN
-9.19%
$1.58
CHR
-5.80%
$0.04
AVGO
-1.16%
$381.57
ASBP
-8.00%
$0.09
AMD
+0.75%
$216.87
MSFT
-1.69%
$481.70
PCG
-0.78%
$15.20
PMAX
+27.97%
$2.90
DRCT
-15.28%
$0.10
RIVN
+2.25%
$17.61
HTOO
+15.71%
$4.05
HOOD
+6.29%
$133.88
PYPL
-2.55%
$61.29
CGC
+4.95%
$1.16
GRYP
-10.38%
$1.38
BTG
+0.56%
$4.45
BMY
+5.64%
$50.97
MODV
-25.22%
$0.43
BAC
+1.67%
$54.08
HBAN
+2.62%
$16.99
GRAB
-0.85%
$5.21
MSTR
+2.50%
$185.87
RGTI
+4.06%
$24.85
GTLB
-13.46%
$37.53
M
+0.61%
$22.85
VIVK
-15.17%
$0.09
PSTG
-26.92%
$69.21
NOK
+1.20%
$6.26
DVLT
-3.19%
$1.82
YGMZ
-13.57%
$0.07
ITUB
+0.19%
$7.90
CRDO
+10.11%
$188.44
ALIT
-2.47%
$2.17
SNAP
+0.13%
$7.63
FCX
+4.22%
$44.78
CRCL
+8.61%
$84.11
ABEV
+1.34%
$2.61
BE
+6.13%
$105.00
GPUS
-2.71%
$0.27
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.